(VIANEWS) - Southwest Airlines (LUV), Verra Mobility Corporation (VRRM), Western Gas Partners, LP Limited Partner Interests (WES) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Southwest Airlines (LUV)
27.4% sales growth and 9.57% return on equity
Southwest Airlines Co. is a scheduled passenger airline that provides services to the United States as well as near-international markets. The company had 728 Boeing 737 planes in its fleet as of December 31, 2021. It served 121 locations in 42 US states and the District of Columbia. The company also offers connectivity and entertainment services in flight on Wi-Fi equipped aircrafts. It has a Rapid Rewards loyalty program which allows program members to accumulate points for every dollar spent on Southwest base tickets. The company also offers an array of digital platforms that support customers' travel needs. These include apps and websites, as well as SWABIZ which is an online booking platform. It also offers ancillary services such as Southwest’s EarlyBird check-in, upgraded boarding and transport of unaccompanied minors and pets. It was founded in 1967 in Dallas, Texas.
Southwest Airlines's sales growth this year is anticipated to be 54.5% and 8.5% for next year.
Year-on-year quarterly revenue growth grew by 67.9%, now sitting on 21.15B for the twelve trailing months.
Volume
Today's last reported volume for Southwest Airlines is 1104700 which is 80.33% below its average volume of 5618880.
Southwest Airlines's sales growth for the next quarter is 27.4%. The company's growth estimates for the present quarter and the next is 495.7% and 492.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.57%.
Volatility
Southwest Airlines's last day, last week, and last month's current intraday variation average was 1.36%, 1.54%, and 1.41%, respectively.
Southwest Airlines's highest amplitude of average volatility was 2.67% (day), 2.73% (last week), and 2.33% (last month), respectively.
Southwest Airlines's Stock Yearly Top and Bottom Value
Southwest Airlines's stock is valued at $36.17 at 11:22 EST, way under its 52-week high of $56.33 and higher than its 52-week low of $34.36.
Southwest Airlines's Moving Average
Southwest Airlines's value is under its 50-day moving average of $38.81 and way below its 200-day moving average of $43.18.2. Verra Mobility Corporation (VRRM)
25.9% sales growth and 30.7% return on equity
Verra Mobility Corporation offers smart mobility solutions and services throughout the United States and Canada. The company operates in two parts, Government Solutions and Commercial Services. Government Solutions offers safety solutions that include services and technology to enable photo enforcement via road safety cameras programs. This detects and processes traffic violations such as red lights, speed, school buses, and bus lanes. This segment is available to municipalities, schools districts and law enforcement agencies. Commercial Services provides toll-free and automated violations management as well title and registration services to fleet managers, rental car companies and large fleet owners. It is located in Mesa Arizona.
Verra Mobility Corporation's sales growth this year is expected to be 32.5% and 5% for next year.
Year-on-year quarterly revenue growth grew by 45.7%, now sitting on 689.95M for the twelve trailing months.
Volume
Today's last reported volume for Verra Mobility Corporation is 958728 which is 14.73% below its average volume of 1124430.
Verra Mobility Corporation's sales growth for the next quarter is 25.9%. The company's growth estimates for the present quarter and the next is 140% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.7%.
Volatility
Verra Mobility Corporation's last day, last week, and last month's current intraday variation average was 1.23%, 1.47%, and 1.52%, respectively.
Verra Mobility Corporation's highest amplitude of average volatility was 3.17% (day), 1.95% (last week), and 2.38% (last month), respectively.
Verra Mobility Corporation's Stock Yearly Top and Bottom Value
Verra Mobility Corporation's stock is valued at $16.46 at 11:23 EST, below its 52-week high of $18.13 and way higher than its 52-week low of $12.70.
Verra Mobility Corporation's Moving Average
Verra Mobility Corporation's value is above its 50-day moving average of $16.14 and higher than its 200-day moving average of $15.70.3. Western Gas Partners, LP Limited Partner Interests (WES)
25.8% sales growth and 36.09% return on equity
Western Midstream Partners, LP and its subsidiaries acquire, own, manage, and develop midstream assets primarily within the United States. The company is responsible for gathering, compressing and treating natural gas, as well as transporting it. It also sells NGLs and natural gas. The company's general partner is Western Midstream Holdings, LLC. In February 2019, the company, formerly called Western Gas Equity Partners LP, changed its name and became Western Midstream Partners LP. The Woodlands is where the company's headquarters are located.
Western Gas Partners, LP Limited Partner Interests's sales growth this year is expected to be 20.2% and 0.2% for next year.
Year-on-year quarterly revenue growth grew by 21.9%, now sitting on 3.12B for the twelve trailing months.
Volume
Today's last reported volume for Western Gas Partners, LP Limited Partner Interests is 776446 which is 29.48% below its average volume of 1101100.
Western Gas Partners, LP Limited Partner Interests's sales growth is a negative 0% for the ongoing quarter and 25.8% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.09%.
Volatility
Western Gas Partners, LP Limited Partner Interests's last day, last week, and last month's current intraday variation average was 1.17%, 0.97%, and 1.78%, respectively.
Western Gas Partners, LP Limited Partner Interests's highest amplitude of average volatility was 3.05% (day), 2.60% (last week), and 3.09% (last month), respectively.
Western Gas Partners, LP Limited Partner Interests's Stock Yearly Top and Bottom Value
Western Gas Partners, LP Limited Partner Interests's stock is valued at $28.25 at 11:23 EST, under its 52-week high of $29.50 and way above its 52-week low of $18.89.
Western Gas Partners, LP Limited Partner Interests's Moving Average
Western Gas Partners, LP Limited Partner Interests's worth is higher than its 50-day moving average of $26.08 and way above its 200-day moving average of $24.65.4. Acadia Healthcare Company (ACHC)
11.4% sales growth and 10.99% return on equity
Acadia Healthcare Company, Inc. is a developer and operator of inpatient and residential psychiatric centers, residential treatment centres, group homes, substance abuse and outpatient behavioral healthcare services to meet the needs of the communities in Puerto Rico and the United States. It operates an acute inpatient mental health facility that stabilizes patients who are dangerously ill. They also provide 24-hour monitoring, intervention and supervision by psychiatrists. The company also has specialty treatment facilities that include residential treatment and eating disorder facilities and holistic treatment centers which offer continuum care to adults suffering from co-occurring and addictive disorders. The company also offers residential treatment centers that treat behavioral disorders and provide therapeutic placements for adolescents and children with emotional disorders. It had approximately 10500 beds in 228 of its behavioral health facilities as of February 28, 2022. Acadia Healthcare Company, Inc. is located in Franklin, Tennessee.
Acadia Healthcare Company's sales growth this year is anticipated to be 11.8% and 8.6% for next year.
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 2.45B for the twelve trailing months.
Volume
Today's last reported volume for Acadia Healthcare Company is 783410 which is 41.52% above its average volume of 553535.
Acadia Healthcare Company's sales growth is a negative 0% for the present quarter and 11.4% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.99%.
Volatility
Acadia Healthcare Company's last day, last week, and last month's current intraday variation average was 3.13%, 1.31%, and 1.08%, respectively.
Acadia Healthcare Company's highest amplitude of average volatility was 4.30% (day), 2.53% (last week), and 2.16% (last month), respectively.
Acadia Healthcare Company's Stock Yearly Top and Bottom Value
Acadia Healthcare Company's stock is valued at $82.64 at 11:24 EST, below its 52-week high of $86.03 and way higher than its 52-week low of $50.07.
Acadia Healthcare Company's Moving Average
Acadia Healthcare Company's value is above its 50-day moving average of $76.77 and way higher than its 200-day moving average of $66.16.5. Pfizer (PFE)
8.9% sales growth and 31.87% return on equity
Pfizer Inc. develops and markets biopharmaceutical products in the world. The company offers medicines and vaccines across a variety of therapeutic areas. It also sells biologics and small molecules under the Eliquis and Premarin brands. It also offers vaccines and medicines in a variety of therapeutic areas such as meningococcal and pneumococcal diseases, tick-borne encephalitis and COVID-19 under Comirnaty/BNT162b2, Nimenrix and Trumenba brands. Biosimilars are available for chronic immuno-inflammatory and inflammatory conditions under the Xeljanz/Vyndamax and Genotropin brand names. The company also has a contract manufacturing division. The company serves pharmacies and individuals, along with government agencies and hospitals. Collaboration agreements were signed with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc., Merck KGaA, Valneva SE, BioNTech SE, and Arvinas, Inc. Pfizer Inc. is headquartered New York, New York.
Pfizer's sales growth this year is anticipated to be 28.8% and a negative 25.2% for next year.
Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 81.29B for the twelve trailing months.
Volume
Today's last reported volume for Pfizer is 6870570 which is 63.43% below its average volume of 18791300.
Pfizer's sales growth for the next quarter is 8.9%. The company's growth estimates for the ongoing quarter and the next is 89.7% and 41%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.87%.
Volatility
Pfizer's last day, last week, and last month's current intraday variation average was 1.37%, 1.14%, and 1.29%, respectively.
Pfizer's highest amplitude of average volatility was 2.55% (day), 1.76% (last week), and 1.74% (last month), respectively.
Pfizer's Stock Yearly Top and Bottom Value
Pfizer's stock is valued at $46.11 at 11:25 EST, way under its 52-week high of $61.71 and way above its 52-week low of $38.82.